CoChat

Continuing Treatment of Depression in the Elderly: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Controlled Trials With Antidepressants

Kok, Rob M., Heeren, Thea J., Nolen, Willem A. · 2011 · The American Journal of Geriatric Psychiatry

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Abstract

Objective To establish the efficacy and tolerability of continuing treatment with antidepressants in preventing relapses and recurrences in elderly depressed patients and to analyze differences between tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).Design The authors conducted a systematic literature search to identify all randomized, placebo-controlled, double-blinded clinical trials(RCTs) in elderly patients. Data were pooled from eight double-blinded RCTs of continuation and maintenance treatment in the elderly with 925 participating patients.Results The number of patients needed to treat (NNT) for antidepressants to prevent one additional relapse or recurrence was 3 6 (95% confidence interval [CI]: 2.8-4.8).The NNT for TCAs was 2.9 (95% CI: 2.2-4.6), compared with a NNT for SSRIs of 4.2(95% CI: 3.2-5.9). In the five studies that provide drop out data, 14 of 330 patients(4.2%) using an antidepressant dropped out due to side effects compared with 17 of 330 patients (5.2%) using a placebo (χ² = 0.305, df = 1, p = 0.581). Tolerability did not differ between TCAs and SSRIs.Conclusion Continuing treatment with antidepressants in elderly patients is efficacious compared with placebo in preventing relapses and recurrences. Efficacy and tolerability during long-term treatment does not differ between TCAs and SSRIs.

Overview

Integrity signals

Registry

Crossref · 10.1097/jgp.0b013e3181ec8085

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. Alexopoulos, 2001, Pharmacotherapy of depressive disorders in older patients, Postgrad Med, 1

Cited by

See all 141

Metadata

Authors
Kok, R. M., Heeren, T. J., & Nolen, W. A.
Affiliations
  • Parnassia Groep (NL)
  • University Medical Center Groningen (NL)
Corresponding author
Kok, Rob M.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2011-03
Volume
19
Issue
3
Pages
249-255
ISSN
1064-7481 (ISSN-L)
OpenAlex
W2095837197
Cited by
141
References
28
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 34 · 2019: 8 · 2018: 7 · 2017: 9 · 2016: 11 · 2015: 11 · 2014: 10 · 2013: 13 · 2012: 17
FWCI
1.27
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • American Journal of Geriatric Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
geriatric depression, continuation treatment, maintenance therapy, antidepressants, tricyclic antidepressants, selective serotonin reuptake inhibitors, relapse prevention, recurrence prevention, treatment efficacy, tolerability, adverse effects
MeSH terms
Aged, Antidepressive Agents, Tricyclic, Depression, Humans, Middle Aged, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuing Treatment of Depression in the Elderly: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Controlled Trials With Antidepressants. https://app.cochat.ai/papers/10.1097/jgp.0b013e3181ec8085
The paper
Kok, R. M., Heeren, T. J., & Nolen, W. A. (2011). Continuing Treatment of Depression in the Elderly: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Controlled Trials With Antidepressants. The American Journal of Geriatric Psychiatry. https://doi.org/10.1097/jgp.0b013e3181ec8085

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.